How telehealth tirzepatide programs differ across compounded cash-pay and FDA-approved brand pathways.
Intake and clinician review
A telehealth service should collect relevant history and route it to a licensed clinician who decides whether a prescription is appropriate.
Product pathway
Ask whether the proposed product is FDA-approved Zepbound/Mounjaro or a compounded tirzepatide preparation.
Payment model
Cash-pay compounded plans and insurance-focused brand programs have different pricing logic.
Follow-up
Know who handles dose changes, adverse effects and refill questions.
Sources & verification
We use primary sources for time-sensitive commercial and regulatory claims.
- HealthRx — About & compounded-medication disclosure
- FDA — Compounding and the FDA: Questions and Answers
- FDA — Concerns with unapproved GLP-1 drugs used for weight loss
Last reviewed: August 19, 2026